Jazz Pharmaceuticals plc — Director's Dealing 2018

May 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2018-05-11

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-11	Ordinary Shares	S	7500	$165.0	Disposed	30747	Direct
2018-05-14	Ordinary Shares	M	8540	$46.83	Acquired	39287	Direct
2018-05-14	Ordinary Shares	M	1691	$59.13	Acquired	40978	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-14	Incentive Stock Option (right to buy)	$46.83	M	8540	Disposed	2022-08-08	Ordinary Shares (8540)	Direct
2018-05-14	Incentive Stock Option (right to buy)	$59.13	M	1691	Disposed	2023-03-04	Ordinary Shares (1691)	Direct

Footnotes

F1: This incentive stock option is part of an option award granted on August 9, 2012. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of August 9, 2012, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.

F2: This incentive stock option is part of an option award granted on March 5, 2013. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of March 5, 2013, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.